Failure of CD4 response (CD4 >500/mm(3)) was associated with age ≥40 years at baseline (P < 0.001), CD4 cell counts ≤500/mm(3) at month 4 (P = 0.016) or month 12 (P < 0.001) and ≥3 months of cART interruption (P = 0.016). Factors associated with failure to achieve complete immunological response (CD4 >500/mm(3) and CD4:CD8 ratio >1) were...
-
2017 (v1)Journal articleUploaded on: February 28, 2023
-
September 15, 2016 (v1)Journal article
BACKGROUND:Human immunodeficiency virus (HIV)/hepatitis C virus (HCV)-coinfected patients with cirrhosis have long been considered to be difficult to treat, and real-life efficacy and tolerance data with all-oral direct-acting antiviral (DAA) combinations in these patients are scarce.METHODS:Cirrhotic HIV/HCV-coinfected patients enrolled in the...
Uploaded on: December 4, 2022 -
2017 (v1)Journal article
No description
Uploaded on: December 3, 2022 -
January 2017 (v1)Journal article
Background & aims - We report the first real-life results of the sofosbuvir+daclatasvir combination in hepatitis C virus (HCV) genotype 1 infected patients. Methods - The France REcherche Nord&Sud Sida-hiv Hépatites (ANRS) CO22 HEPATHER "Therapeutic options for hepatitis B and C: A French cohort" is a multicentre observational cohort which...
Uploaded on: February 27, 2023